Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Completed

Phase of Trial:
Phase II

Latest Information Update:06 Dec 2016

At a glance

Drugs
Dasatinib (Primary)

Indications
Chronic myeloid leukaemia

Focus
Therapeutic Use

Acronyms
IMIDAS

Most Recent Events

06 Dec 2016
Results assessing the efficacy and safety of dasatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology

08 Dec 2015
Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology

27 Oct 2015
Results published in the European Journal of Clinical Pharmacology

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription